Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - Net
Ratios

Tandem Diabetes Care (TNDM) Leases (2019 - 2025)

Tandem Diabetes Care's Leases history spans 7 years, with the latest figure at $96.2 million for Q4 2025.

  • For Q4 2025, Leases rose 12.74% year-over-year to $96.2 million; the TTM value through Dec 2025 reached $96.2 million, up 12.74%, while the annual FY2025 figure was $96.2 million, 12.74% up from the prior year.
  • Leases reached $96.2 million in Q4 2025 per TNDM's latest filing, down from $98.4 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $126.7 million in Q2 2022 to a low of $15.1 million in Q1 2021.
  • Average Leases over 5 years is $84.1 million, with a median of $90.2 million recorded in 2023.
  • Peak YoY movement for Leases: skyrocketed 1249.23% in 2021, then dropped 28.12% in 2023.
  • A 5-year view of Leases shows it stood at $27.5 million in 2021, then soared by 302.23% to $110.6 million in 2022, then decreased by 20.64% to $87.8 million in 2023, then dropped by 2.83% to $85.3 million in 2024, then grew by 12.74% to $96.2 million in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Leases are $96.2 million (Q4 2025), $98.4 million (Q3 2025), and $98.4 million (Q2 2025).